Warning: The NCBI web site requires JavaScript to function. more...
Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.
Hoogenveen RT, van Baal PH, Boshuizen HC, Feenstra TL.
Cost Eff Resour Alloc. 2008 Jan 11;6:1.
Related citations
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking.
Hurley SF, Matthews JP.
Cost Eff Resour Alloc. 2007 Jan 23;5:2.
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
Cahill K, Ussher M.
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005353. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD005353.
Relapse prevention interventions for smoking cessation.
Hajek P, Stead LF, West R, Jarvis M, Lancaster T.
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003999. Review.
Interventions for smoking cessation in hospitalised patients.
Rigotti NA, Munafo MR, Stead LF.
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001837. Review.
[Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J, Säwe U.
J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.
Hajek P, Stead LF, West R, Jarvis M.
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003999. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD003999.
Patterns of absolute risk of lung cancer mortality in former smokers.
Halpern MT, Gillespie BW, Warner KE.
J Natl Cancer Inst. 1993 Mar 17;85(6):457-64.
Duration of smoking abstinence and success in quitting.
Gilpin EA, Pierce JP, Farkas AJ.
J Natl Cancer Inst. 1997 Apr 16;89(8):572-6.
Tobacco industry research on smoking cessation. Recapturing young adults and other recent quitters.
Ling PM, Glantz SA.
J Gen Intern Med. 2004 May;19(5 Pt 1):419-26. Review.
Modelling the health benefits of smoking cessation in Japan.
Avila-Tang E, Apelberg BJ, Yamaguchi N, Katanoda K, Sobue T, Samet JM.
Tob Control. 2009 Feb;18(1):10-7. Epub 2008 Aug 26. Review.
The global impact of noncommunicable diseases: estimates and projections.
Manton KG.
World Health Stat Q. 1988;41(3-4):255-66.
'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.
Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.
Patterns of motivations and ways of quitting smoking among Polish smokers: a questionnaire study.
Sieminska A, Buczkowski K, Jassem E, Lewandowska K, Ucinska R, Chelminska M.
BMC Public Health. 2008 Aug 4;8:274.
A prospective investigation of the impact of smoking bans on tobacco cessation and relapse.
Longo DR, Johnson JC, Kruse RL, Brownson RC, Hewett JE.
Tob Control. 2001 Sep;10(3):267-72.
Physician advice for smoking cessation.
Stead LF, Bergson G, Lancaster T.
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000165. Review.
ASPO Joseph W. Cullen Memorial Award Lecture. Bridging the clinical and public health perspectives in tobacco treatment research: scenes from a tobacco treatment research career.
Curry SJ.
Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):281-5.
Older adults and smoking.
LaCroix AZ, Omenn GS.
Clin Geriatr Med. 1992 Feb;8(1):69-87. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on